Extra filter added to dialysis aims to ease patient suffering
NCT ID NCT05639010
Summary
This study is testing if adding a special blood filter, called hemoperfusion, to regular dialysis treatments helps remove more harmful toxins from the blood. It involves 410 adults with end-stage kidney disease who are already on stable dialysis. Researchers will compare standard dialysis to dialysis plus the extra filter to see if it improves toxin levels, sleep, itching, and overall quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.